IA
CRDF icon

Integrity Alliance’s Cardiff Oncology CRDF Stock Holding History

Integrity Alliance’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.8K Hold
12,860
– – ﹤0.01% 752
2025
Q4 		$36.1K Hold
12,860
– – ﹤0.01% 777
2025
Q3 		$26.5K Hold
12,860
– – ﹤0.01% 561
2025
Q2 		$40.5K Buy
+12,860
New +$39.2K ﹤0.01% 470

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Integrity Alliance's CRDF Position: Q1 2026 in Review

Integrity Alliance held its Cardiff Oncology (CRDF) position steady in Q1 2026 at 12,860 shares worth $20.8K. The position accounts for ﹤0.01% of the portfolio, ranked #752.

Integrity Alliance first reported a position in CRDF in Q2 2025 and has held it in 4 quarters since. The position peaked at $40.5K in Q2 2025. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Integrity Alliance held 12,860 shares of Cardiff Oncology worth $20.8K as of Q1 2026.
  • Integrity Alliance left its Cardiff Oncology share count unchanged in Q1 2026.
  • Cardiff Oncology made up ﹤0.01% of Integrity Alliance's portfolio in Q1 2026, its #752 holding.
  • Integrity Alliance first reported a position in Cardiff Oncology in Q2 2025 and has held it in 4 quarters since.
  • Integrity Alliance's Cardiff Oncology position peaked at $40.5K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Integrity Alliance's 13F filing for Q1 2026, filed 11 May 2026.